MedTrace Logo

Health Effects of Taekwondo Training for Elderly Over the Age of 60 Years

NCT07451288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-05

No results posted yet for this study

Summary

This randomized controlled trial investigates the effects of a 10-week Taekwondo (TKD) training intervention on physical and cognitive function in community-dwelling adults aged 60 years and older. Participants are randomly allocated to either an intervention group undertaking supervised Taekwondo training twice weekly or to a waiting-list control group maintaining usual activity for 10 weeks before receiving the same intervention.

The primary aim is to determine whether structured Taekwondo training improves balance performance compared to a control condition. Secondary outcomes include lower- and upper-body muscular strength, cardiorespiratory fitness (VO₂max), blood pressure, body composition, and selected cognitive outcomes.

Assessments are conducted at baseline and after the 10-week intervention period. A 1-year follow-up assessment is included to examine long-term maintenance of effects. The study is designed to evaluate whether Taekwondo represents a safe, feasible, and effective multimodal training approach for promoting physical function and healthy ageing in older adults.

Conditions

  • Aging
  • Physical Activity in Adults

Interventions

BEHAVIORAL

Taekwondo training

Tkd training two times a week for ten weeks

Sponsors & Collaborators

  • Vegard Vereide Iversen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-06-25
Completion
2025-06-25

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07451288 on ClinicalTrials.gov